ACHILLION PHARMACEUTICALS IN's ticker is ACHN and the CUSIP is 00448Q201. A total of 163 filers reported holding ACHILLION PHARMACEUTICALS IN in Q3 2016. The put-call ratio across all filers is 0.46 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $3,680,000 | +30.0% | 1,000,000 | 0.0% | 0.10% | +32.4% |
| Q2 2018 | $2,830,000 | -23.7% | 1,000,000 | 0.0% | 0.07% | -28.8% |
| Q1 2018 | $3,710,000 | +28.8% | 1,000,000 | 0.0% | 0.10% | +9.5% |
| Q4 2017 | $2,880,000 | -61.7% | 1,000,000 | +7.6% | 0.10% | -80.5% |
| Q3 2016 | $7,527,000 | +479.0% | 929,290 | +775.9% | 0.49% | +345.9% |
| Q4 2014 | $1,300,000 | -23.4% | 106,100 | -37.6% | 0.11% | -40.1% |
| Q3 2014 | $1,697,000 | -20.0% | 170,000 | -39.3% | 0.18% | -12.5% |
| Q2 2014 | $2,120,000 | – | 280,000 | – | 0.21% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 6,700,000 | $66,866,000 | 7.90% |
| RA Capital Management | 3,000,000 | $29,940,000 | 3.54% |
| Camber Capital Management LP | 3,250,000 | $32,435,000 | 3.05% |
| DOHENY ASSET MANAGEMENT /CA | 542,325 | $5,412,000 | 2.71% |
| QVT Financial LP | 2,504,677 | $24,997,000 | 1.29% |
| Atika Capital Management LLC | 123,700 | $1,235,000 | 0.95% |
| Rhenman & Partners Asset Management AB | 200,000 | $1,996,000 | 0.58% |
| Bain Capital Public Equity Management, LLC | 2,246,632 | $22,421,000 | 0.58% |
| BB BIOTECH AG | 1,279,340 | $12,768,000 | 0.52% |
| EAM Investors, LLC | 222,842 | $2,224,000 | 0.45% |